Goodwill E-Health Info Co., Ltd. (SHA:688246)
China · Delayed Price · Currency is CNY 17.19
+0.05 (0.29%)
Sep 8, 2026, 11:29 AM CST
Goodwill E-Health Info Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 359.01 | 404.12 | 591.94 | 695.18 | 716.95 | 651.94 | |
Revenue Growth | -29.63% | -31.73% | -14.85% | -3.04% | 9.97% | 22.58% |
Cost of Revenue | 307.41 | 350.26 | 429.06 | 355.99 | 355.96 | 326.18 |
Gross Profit | 51.6 | 53.86 | 162.89 | 339.19 | 360.99 | 325.76 |
Selling, General & Admin | 153.38 | 170.89 | 184.89 | 195.93 | 191.33 | 177.72 |
Research & Development | 110.83 | 125.11 | 136.21 | 137.39 | 147.02 | 117.04 |
Other Operating Expenses | -6.85 | -4.66 | -14.78 | -13.35 | -8.74 | -17.31 |
Operating Expenses | 298.98 | 332.97 | 376.25 | 354.35 | 362.07 | 305.32 |
Operating Income | -247.39 | -279.11 | -213.37 | -15.17 | -1.08 | 20.44 |
Interest Expense | -9.77 | -9.77 | -9.82 | -2.74 | -1.68 | -6.11 |
Interest & Investment Income | 0.96 | 0.96 | 3.86 | 10.08 | 17.38 | 1.66 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | 0 | 0 | -0.02 |
Other Non Operating Income (Expenses) | 9.25 | -1.35 | -2.89 | -1.49 | -1.35 | -2.55 |
EBT Excluding Unusual Items | -246.94 | -289.27 | -222.22 | -9.32 | 13.27 | 13.44 |
Gain (Loss) on Sale of Investments | -10.28 | -11.82 | -12.85 | - | - | -0.04 |
Gain (Loss) on Sale of Assets | 0.19 | - | 0.05 | -0 | -0 | 0.04 |
Asset Writedown | 1.68 | -0.12 | - | -0.07 | -0.08 | -0.06 |
Other Unusual Items | 6.31 | 6.31 | 5.09 | 4.73 | 14.18 | 13.05 |
Pretax Income | -249.04 | -294.9 | -229.92 | -4.67 | 27.37 | 26.43 |
Income Tax Expense | -22.99 | -23.2 | 68.29 | -14.74 | -13.36 | -6.46 |
Earnings From Continuing Operations | -226.05 | -271.7 | -298.22 | 10.07 | 40.73 | 32.89 |
Minority Interest in Earnings | 11.84 | 21.22 | 42.1 | 22.22 | 27.29 | 16.72 |
Net Income | -214.21 | -250.49 | -256.12 | 32.28 | 68.02 | 49.61 |
Net Income to Common | -214.21 | -250.49 | -256.12 | 32.28 | 68.02 | 49.61 |
Net Income Growth | - | - | - | -52.54% | 37.13% | 133.27% |
Shares Outstanding (Basic) | 138 | 138 | 138 | 140 | 139 | 103 |
Shares Outstanding (Diluted) | 138 | 138 | 138 | 140 | 139 | 103 |
Shares Change | 0.57% | -0.05% | -1.90% | 1.11% | 34.33% | 2.06% |
EPS (Basic) | -1.55 | -1.82 | -1.86 | 0.23 | 0.49 | 0.48 |
EPS (Diluted) | -1.55 | -1.82 | -1.86 | 0.23 | 0.49 | 0.48 |
EPS Growth | - | - | - | -53.06% | 2.08% | 128.57% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -66.1 | -178.66 | -203.46 | -208.6 | -329.16 | -214.03 |
Free Cash Flow Per Share | -0.48 | -1.30 | -1.48 | -1.49 | -2.37 | -2.07 |
Gross Margin | 14.37% | 13.33% | 27.52% | 48.79% | 50.35% | 49.97% |
Operating Margin | -68.91% | -69.07% | -36.05% | -2.18% | -0.15% | 3.14% |
Profit Margin | -59.67% | -61.98% | -43.27% | 4.64% | 9.49% | 7.61% |
Free Cash Flow Margin | -18.41% | -44.21% | -34.37% | -30.01% | -45.91% | -32.83% |
EBITDA | -240.44 | -276.3 | -204.41 | -7.19 | 2.55 | 23.9 |
EBITDA Margin | -66.97% | -68.37% | -34.53% | -1.03% | 0.36% | 3.67% |
D&A For EBITDA | 6.95 | 2.81 | 8.95 | 7.98 | 3.64 | 3.46 |
EBIT | -247.39 | -279.11 | -213.37 | -15.17 | -1.08 | 20.44 |
EBIT Margin | -68.91% | -69.07% | -36.05% | -2.18% | -0.15% | 3.14% |
Revenue as Reported | 404.12 | 404.12 | 591.94 | 695.18 | 716.95 | 651.94 |